Meloxicam Pharmaceutical Composition and Application
Summary
The USPTO has published a patent application (US20260083748A1) for a pharmaceutical composition containing meloxicam, a composite solvent, and an acidic pH regulator. The assignee is Beijing Tide Pharmaceutical Co., Ltd. This application details a preparation method and its application, focusing on a formulation that avoids organic solvents for increased safety and reduced environmental impact.
What changed
The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083748A1, filed by Beijing Tide Pharmaceutical Co., Ltd. The application describes a pharmaceutical composition containing meloxicam, a composite solvent (including a polymer compound like cyclodextrin derivatives), and an acidic pH regulator. Notably, the composition is designed to be free of organic solvents, aiming to enhance drug safety by avoiding adverse reactions and to reduce environmental pollution during manufacturing.
This publication represents a new intellectual property filing related to drug formulation. While patent applications do not impose direct compliance obligations on other entities, they signal potential future market exclusivity for the assignee's technology. Companies involved in the development or manufacturing of meloxicam-based therapeutics should be aware of this filing as it may impact future product development and market entry strategies. No immediate compliance actions are required for other entities based solely on this patent application publication.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHARMACEUTICAL COMPOSITION CONTAINING MELOXICAM, A PREPARATION METHOD, AND AN APPLICATION THEREOF
Application US20260083748A1 Kind: A1 Mar 26, 2026
Assignee
Beijing Tide Pharmaceutical Co., Ltd.
Inventors
Wanjun LIU, Jingjing ZHANG, Zhibing ZHANG, Zaiying WANG, Di LU, Zhiyang YUE, Leling GAN
Abstract
The present invention provides a pharmaceutical composition containing meloxicam, a preparation method thereof, and an application thereof. The pharmaceutical composition includes meloxicam, a composite solvent, and an acidic pH regulator. The composite solvent includes a polymer compound, an alkaline compound, and an aqueous solution. The polymer compound is selected from cyclodextrin or synthetic cyclodextrin and derivatives thereof. The meloxicam composition of the present invention does not contain any organic solvent, which can effectively avoid generation of adverse reactions of pharmaceutical formulations, make drug use safer, and at the same time also reduce the environmental pollution during the preparation process of the drug.
CPC Classifications
A61K 31/5415 A61J 1/1412 A61J 1/1468 A61K 9/0019 A61K 9/08 A61K 9/1611 A61K 9/1617 A61K 9/1652 A61K 9/19 A61K 47/02 A61K 47/12 A61K 47/40 A61P 29/00
Filing Date
2025-09-23
Application No.
19336937
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.